Similarly, in another study that used a PRM assay to quantify proteins extracted from formalin-fixed paraffin-embedded tissue slides, multiple peptides from the HER2 protein exhibited differential performance in discriminating breast cancer subtypes among a cohort of 51 patients [65]. This evidence concerns the gene ERBB2 and breast cancer.